WHO advises doctors not to use Gilead’s remdesivir for COVID-19

who advises doctors not to use gileads remdesivir for covid 19

Sumary of WHO advises doctors not to use Gilead’s remdesivir for COVID-19:

  • The recommendation is a blow to Gilead drug, which was one of the first thought to offer a meaningful benefit in treatment of coronavirus patients after a study showed it reduced their recovery time..
  • The experts made the recommendation after the results of a global trial sponsored by the WHO, called Solidarity, found last month that remdesivir didn’t reduce deaths..
  • Food and Drug Administration approved the drug a week later, basing its decision on a trial run by the National Institutes of Health that showed remdesivir reduced hospitalized patients’ recovery time by five days..
  • Multiple studies published in peer-reviewed journals have show remdesivir, also known by its brand name, Veklury, is beneficial against the virus, particularly in improving recovery time, “which can free up limited hospital resources,”.
  • Despite the discordance with the WHO, the FDA said in its review of remdesivir that “there were no issues identified that would benefit from discussion”…

Want to know more click here go to health news source.

From -

Close

Languages